Michael G Carter - Net Worth and Insider Trading
Michael G Carter Net Worth
The estimated net worth of Michael G Carter is at least $5,719 dollars as of 2024-09-20. Michael G Carter is the Director of Oncternal Therapeutics Inc and owns about 3,597 shares of Oncternal Therapeutics Inc (ONCT) stock worth over $5,719. Details can be seen in Michael G Carter's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael G Carter has not made any transactions after 2020-09-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael G Carter
Michael G Carter Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael G Carter owns 1 companies in total, including Oncternal Therapeutics Inc (ONCT) .
Click here to see the complete history of Michael G Carter’s form 4 insider trades.
Insider Ownership Summary of Michael G Carter
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ONCT | Oncternal Therapeutics Inc | 2020-09-01 | director |
Michael G Carter Latest Holdings Summary
Michael G Carter currently owns a total of 1 stock. Michael G Carter owns 3,597 shares of Oncternal Therapeutics Inc (ONCT) as of September 1, 2020, with a value of $5,719.
Latest Holdings of Michael G Carter
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ONCT | Oncternal Therapeutics Inc | 2020-09-01 | 3,597 | 1.59 | 5,719 |
Holding Weightings of Michael G Carter
Michael G Carter Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael G Carter has made a total of 1 transactions in Oncternal Therapeutics Inc (ONCT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Oncternal Therapeutics Inc is the acquisition of 3,571 shares on September 1, 2020, which cost Michael G Carter around $150,001.
Insider Trading History of Michael G Carter
- 1
Michael G Carter Trading Performance
GuruFocus tracks the stock performance after each of Michael G Carter's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael G Carter is 46.73%. GuruFocus also compares Michael G Carter's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael G Carter within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael G Carter's insider trading performs compared to the benchmark.
Performance of Michael G Carter
Michael G Carter Ownership Network
Michael G Carter Owned Company Details
What does Oncternal Therapeutics Inc do?
Who are the key executives at Oncternal Therapeutics Inc?
Michael G Carter is the director of Oncternal Therapeutics Inc. Other key executives at Oncternal Therapeutics Inc include director & Executive Chairman Robert James Wills , Chief Scientific Officer Gunnar F. Kaufmann , and Chief Medical Officer Salim Yazji .
Oncternal Therapeutics Inc (ONCT) Insider Trades Summary
Over the past 18 months, Michael G Carter made no insider transaction in Oncternal Therapeutics Inc (ONCT). Other recent insider transactions involving Oncternal Therapeutics Inc (ONCT) include a net purchase of 9,020 shares made by Robert James Wills , a net purchase of 150,000 shares made by James B Breitmeyer , and a net purchase of 30,000 shares made by Richard G Vincent .
In summary, during the past 3 months, insiders sold 0 shares of Oncternal Therapeutics Inc (ONCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 980 shares of Oncternal Therapeutics Inc (ONCT) were sold and 23,880 shares were bought by its insiders, resulting in a net purchase of 22,900 shares.
Oncternal Therapeutics Inc (ONCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncternal Therapeutics Inc Insider Transactions
Michael G Carter Mailing Address
Above is the net worth, insider trading, and ownership report for Michael G Carter. You might contact Michael G Carter via mailing address: C/o Cancer Vax Corp, 2110 Rutherford Road, Carlsbad Ca 92008.